Julianne Lee

A Dalhousie University researcher presents early-stage findings on chaga mushrooms and marine phytoplankton in cancer cell lines and case-based observations, with the central claim that the combination shows selective cytotoxicity against malignant cells. The mainstream evidence base for chaga in cancer is limited to in vitro studies, animal models, and small case series — translating these to clinical efficacy in living dogs or humans requires substantially more research. Marine phytoplankton currently has very limited clinical evidence in cancer treatment. The episode's strongest framing (comparable efficacy to chemotherapy without side effects) substantially overstates what current evidence supports and could lead families to delay or avoid proven cancer treatments. The interest area is legitimate; the specific protocol is preliminary. Mainstream veterinary oncology continues to recommend conventional treatment (surgery, chemotherapy, radiation, increasingly immunotherapy) as the evidence base for cancer outcomes; integrative supplements can be discussed with a veterinarian as supportive layers rather than substitutes.